Login
$OKYO
$1.44 +$0.04 (2.86%) Close

$OKYO 4 SEC Filings

Filed On Filing
29 Jul 2026 Form 4: Patil Rajkumar V., Chief Scientific Officer

Received 3,363 shares as a grant or award ($5.01K)

23 Jul 2026 Form 4: Dempsey Robert John, Director

Received 15,000 shares as a grant or award ($23.1K)

23 Jul 2026 Form 4: Cerrone Gabriele M, Director

Received 22,500 shares as a grant or award ($32.6K)

23 Jul 2026 Form 4: Jacob Gary S, Director

Received 3,500 shares as a grant or award ($4.9K)

23 Jul 2026 Form 4: Brancaccio John P, Director

Received 5,000 shares as a grant or award ($7.39K)

22 Jul 2026 Form 4: Mantelli Flavio, CHIEF MEDICAL OFFICER

Received 20,000 shares as a grant or award ($28K)

21 Jul 2026 Form 4: Cerrone Gabriele M, Director

Received 25,000 shares as a grant or award ($35K)

10 Jun 2026 Form 4: Denoyer Bernard, Director

Granted 3,500 Option ($6.48K)

10 Jun 2026 Form 4: Brancaccio John P, Director

Granted 6,500 Option ($12K)

10 Jun 2026 Form 4: Simon Willy Jules, Director

Granted 6,500 Option ($12K)

10 Jun 2026 Form 4: Shah Keeren Rameshchandra, Chief Financial Officer

Granted 40,000 Option ($74K)

10 Jun 2026 Form 4: Cerrone Gabriele M, Director

Received 300,000 shares as a grant or award ($516K)

31 Oct 2023 Form 4: Cerrone Gabriele M, Director

Acquired 499,468 shares (Other Transaction) ($749K) · Acquired 70,071 shares (Other Transaction) ($105K)

28 Sep 2023 Form 4: Brancaccio John P, Director

Bought 16,670 shares ($25K)

20 May 2022 Form 4: Cerrone Gabriele M, Director

Bought 5,800,000 shares ($441K)

19 May 2022 Form 4: Jacob Gary S, Director

Bought 12,500 shares ($50K)

19 May 2022 Form 4: Cerrone Gabriele M, Director

Bought 37,500 shares ($150K)

18 May 2022 Form 4: Cerrone Gabriele M, Director

Bought 1,625,000 shares ($96.7K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support